What is new in this third edition
Why COPD is important
How important is COPD?
What is the economic burden of COPD?
Small airways disease
COPD – a mixed spectrum of diseases
Presentation and history
lung function tests
Early screening for COPD
Making the diagnosis and establishing a baseline
Excluding alternative and coexisting pathologies
Disability and handicap
Assessing walking distance
Assessing the impact of the disease on daily activities
Impact of the disease on psychosocial functioning
Assessing health status
Why do people smoke?
How can smokers stop smoking?
Nicotine replacement therapy
Helping patients to stop smoking
How do bronchodilators work?
Long-acting inhaled bronchodilators
Oral long-acting bronchodilators
The rationale for using corticosteroids
The NICEguidelines advice on inhaled steroids in COPD
New clinical information on inhaled steroids
What are the implications for primary care?
Is there a role for long-term oral steroids?
Steroids for acute exacerbations
Evidence for the effectiveness of rehabilitation in COPD
Why rehabilitation programmes are needed
The role of the primary health care team
Other forms of therapy
Social and psychological issues
Severe breathlessness and palliative care
and referral to hospital
Deﬁning an exacerbation
Management of the acute exacerbation
Natural history of an exacerbation
Treatment in the community
Prevention of acute exacerbations
Hospital-at-home schemes for acute exacerbations
Treatment of associated conditions
Consideration of specialist referral
Making a diagnosis
COPD – a multi-system disease
New recommendations on drug treatment
Treatment of exacerbations
Self-management action plans
Assessment of patients with COPD
Follow-up and monitoring in primary care
The GOLD guidelines
What is GOLD?
The GOLD deﬁnition of COPD
Goals of management
Assessing and monitoring disease
Reducing risk factors
Managing stable COPD
Drug therapy of the future
and training needs
Finding the patients
The practice nurse’s role
Protocol and audit
PRIORITY ORDER FORM